Terray Therapeutics is a biotechnology company that transforms small molecule drug discovery.
Terray Therapeutics has raised $120.0M in total funding. The most recent round was Series B. The last funding was announced in October 2024.
Terray Therapeutics's investors include Madrona, Two Sigma Ventures, XTX Ventures, Goldcrest Capital, KdT Ventures.
Terray Therapeutics is headquartered in Monrovia, United States.
Terray Therapeutics is a biotechnology company that transforms small molecule drug discovery.
Terray Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Terray Therapeutics — Funding & Investors." VCBacked, October 17, 2024, https://www.vcbacked.co/company/terray-therapeutics. Accessed October 29, 2026.
VCBacked. (2024). Terray Therapeutics — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/terray-therapeutics
{{cite web |title=Terray Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/terray-therapeutics |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated